Cobb Dustin A, Kim Ok-Kyung, Golden-Mason Lucy, Rosen Hugo R, Hahn Young S
Beirne B. Carter Center for Immunology Research, University of Virginia, Charlottesville, VA.
Department of Gastroenterology, University of Colorado Health Sciences Center, Aurora, CO.
Hepatology. 2018 Jan;67(1):71-85. doi: 10.1002/hep.29409. Epub 2017 Nov 15.
Hepatitis C virus (HCV) is a global health concern that can cause severe liver disease, such as cirrhosis and hepatocellular carcinoma. Control of HCV requires vigorous T-cell responses, yet CD4 T cells in chronic HCV patients are dysfunctional. T follicular regulatory (Tfr) cells are a subset of regulatory T cells that suppress T follicular helper (Tfh) cells and the generation of high affinity antibody-producing B cells. In this study, we examined the accumulation of Tfr cells in the liver compartment during chronic HCV infection and defined the cellular and molecular mechanisms underlying their expansion. Our analysis revealed a substantial population of Tfr cells in livers of chronic HCV patients that is absent in liver tissues from nonviral hepatitis or healthy subjects. Coculture of PBMCs from healthy subjects with HCV-infected hepatoma cells resulted in preferential expansion of circulating Tfr cells, leading to suppression of Tfh cells. Additionally, coculture of tonsillar cells with infected hepatoma cells lead to an expansion of germinal center Tfr. Notably, expansion was mediated by transforming growth factor beta (TGF-β)-containing exosomes released from HCV-infected hepatocytes given that blockade of exosome-associated TGF-β or inhibition of exosome release abrogated Tfr expansion.
These results show that liver-derived exosomes play a pivotal role in the accumulation of Tfr cells, likely leading to suppression of Tfh responses in HCV-infected patients. Our study identifies a novel pathway in which HCV infection in hepatocytes exacerbates Tfr cell responses to subvert antiviral immunity. (Hepatology 2018;67:71-85).
丙型肝炎病毒(HCV)是一个全球健康问题,可导致严重的肝脏疾病,如肝硬化和肝细胞癌。控制HCV需要有力的T细胞反应,但慢性HCV患者的CD4 T细胞功能失调。滤泡调节性T(Tfr)细胞是调节性T细胞的一个亚群,可抑制滤泡辅助性T(Tfh)细胞以及产生高亲和力抗体的B细胞的生成。在本研究中,我们检测了慢性HCV感染期间肝脏中Tfr细胞的积累情况,并确定了其扩增的细胞和分子机制。我们的分析显示,慢性HCV患者肝脏中有大量Tfr细胞,而在非病毒性肝炎或健康受试者的肝脏组织中则不存在。健康受试者的外周血单核细胞(PBMC)与HCV感染的肝癌细胞共培养导致循环Tfr细胞优先扩增,从而抑制Tfh细胞。此外,扁桃体细胞与感染的肝癌细胞共培养导致生发中心Tfr细胞扩增。值得注意的是,扩增是由HCV感染的肝细胞释放的含转化生长因子β(TGF-β)的外泌体介导的,因为外泌体相关TGF-β的阻断或外泌体释放的抑制消除了Tfr细胞的扩增。
这些结果表明,肝脏来源的外泌体在Tfr细胞的积累中起关键作用,可能导致HCV感染患者Tfh反应受到抑制。我们的研究确定了一种新的途径,即肝细胞中的HCV感染加剧Tfr细胞反应以破坏抗病毒免疫。(《肝脏病学》2018年;67:71 - 85)